Top

Published in:

01-05-2009

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience

Authors: Jeryong Kim, Jinsun Lee, Eilsung Chang, Seongmin Kim, Kwangsun Suh, Jiyoung Sul, Insang Song, Yonghoon Kim, Chuljoo Lee

Published in: World Journal of Surgery | Issue 5/2009

Abstract

Background

This study was designed to determine whether a preoperative fluorodeoxyglucose (FDG) positron emission tomography (PET) integrated with computed tomography (CT) (FDG-PET/CT) could be used as a guide for axillary node dissection (AND) or sentinel lymph node biopsy (SNB) in breast cancer patients.

Methods

Between February 2007 and April 2008, we performed FDG-PET/CT scans in 137 biopsy-proven breast cancer patients planning to have an SNB to select patients for either AND (PET/CT N+) or SNB (PET/CT N0). In performing SNB, we also performed additional non-SNB (ADD), which was enlarged at the lower axilla.

Results

Twenty-seven patients with positive scans underwent complete AND as a primary procedure, and 110 patients with negative scans underwent SNB + ADD. There were 8 cases of false negative scans, and no case of false positive scan. The overall sensitivity, specificity, positive predictive value, and overall accuracy of FDG-PET/CT in predicting axillary metastasis were 77.1%, 100%, 100%, and 94.2%, respectively. In a subset of 110 patients with SNB + ADD, 104 patients had histologically negative SN, and 6 patients had positive SN in frozen section. Among 110 SNB + ADD cases, there were only 8 cases (7.3%) of positive axillary basins in permanent biopsy, including two cases of late positives that had micrometastases in the SN only. Through selective SNB + ADD based on an FDG-PET/CT, we have spared 27 unnecessary SNBs (true positive scans).

Conclusions

FDG-PET/CT is a specific imaging modality for predicting axillary node metastasis, and allows for a selective approach to either AND or SNB. A selective SNB + ADD based on an FDG-PET/CT reduced both unnecessary SNBs and positive axillary basins, enhancing the identification rates of SN and the accuracy of SNB.

Carmichael AR (2008) A randomized controlled clinical trial on sentinel node lymph node dissection versus axillary lymph node dissection: a matter of technique or patient selection? Ann Surg 248:895–896PubMedCrossRef

Krag D, Weaver D, Ashikaga T et al (1998) The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 339:941–946PubMedCrossRef

Lovrics PJ, Chen V, Coates G et al (2004) A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol 11:846–853PubMedCrossRef

Kumar R, Jana S, Heiba SI et al (2003) Retrospective analysis of sentinel lymph node localization in multicentric palpable and non-palpable breast cancer. J Nucl Med 44:7–10PubMed

Wong SL, Edwards MJ, Chao C et al (2002) The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J 8:192–198PubMedCrossRef

Vargas HI, Vargas MP, Venegas R et al (2003) Lymphatic tumor burden negatively impacts the ability to detect the sentinel lymph node in breast cancer. Am Surg 69:886–890PubMed

Keskek M, Balas S, Gokoz A et al (2006) Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer. Surg Today 36:1047–1052PubMedCrossRef

Shivers S, Cox C, Leight G et al (2002) Final results of the department of defense multicenter breast lymphatic mapping trial. Ann Surg Oncol 9:248–255PubMedCrossRef

Reske SN, Kotzerke J (2001) FDG-PET for clinical use: results of the 3rd German Interdisciplinary Consensus Conference. “Onko-PET III”, 21 July and 19 September 2000. Eur J Nucl Med 28:1707–1723PubMedCrossRef

10.

Kao CH, Hsieh JF, Tsai SC et al (2000) Comparison and discrepancy of 18F–2-deoxyglucose positron emission tomography and Tc-99 m MDP bone scan to detect bone metastasis. Anticancer Res 20:2189–2192PubMed

11.

Kostakoglu L, Goldsmith SJ (2003) ¹⁸F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 44:224–239PubMed

12.

Eubank WB, Mankoff DA, Vesselle HJ et al (2002) Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics 22:5–17PubMedCrossRef

13.

Bockisch A, Brandt-Mainz K, Gorges R et al (2003) Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner. Acta Med Austriaca 30:22–25PubMedCrossRef

14.

Ueda S, Tsuda H, Asakawa H et al (2008) Utility of ¹⁸F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (¹⁸F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 8:165PubMedCrossRef

15.

De Kanter AY, Van Eijck CHJ, Van Geel AN et al (1999) Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86:1459–1462PubMedCrossRef

16.

Sapino A, Cassoni P, Zanon E et al (2003) Ultrasonographically guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88:702–706PubMedCrossRef

17.

Motomura K, Inaji H, Komoike Y et al (2001) Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients. Eur J Surg Oncol 27:141–145PubMedCrossRef

18.

Kuenen-Boumeester V, Menke-Pluymers M, De Kanter AY et al (2003) Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 39:170–174

19.

Guller U, Nitzsche EU, Schipr U et al (2002) Selective axillary surgery in breast cancer patients based on positron emission tomography with ¹⁸F-fluoro-2-deoxy-D-glucose: not yet! Breast Cancer Res Treat 71:171–173PubMedCrossRef

20.

Yang JH, Nam SJ, Lee TS et al (2001) Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients. Jpn J Clin Oncol 31:1–6PubMedCrossRef

21.

Van der Hoeven JJ, Hoekstra OS, Comans EF et al (2002) Determinants of diagnostic performance of [F-18] fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg 236:619–624PubMedCrossRef

22.

Wahl RL, Siegel BA, Coleman RE et al (2004) Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the Staging Breast Cancer with PET Study Group. J Clin Oncol 22:277–285PubMedCrossRef

23.

Fehr MK, Hornung R, Varga Z et al (2004) Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J 10:89–93PubMedCrossRef

24.

Avril N, Rose CA, Schelling M et al (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18:3495–3502PubMed

25.

Fournier K, Schiller A, Perry RR et al (2004) Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 239:859–863PubMedCrossRef

26.

Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152–158PubMed

27.

Barranger E, Grahek D, Antoine M et al (2003) Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol 10:622–627PubMedCrossRef

Title: Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience
Authors: Jeryong Kim
Jinsun Lee
Eilsung Chang
Seongmin Kim
Kwangsun Suh
Jiyoung Sul
Insang Song
Yonghoon Kim
Chuljoo Lee
Publication date: 01-05-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 5/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-9955-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2009

Outcome of the Rhomboid Flap for Recurrent Pilonidal Disease

Smoking Knowledge, Attitudes, Behavior, and Associated Factors Among Chinese Male Surgeons

Reply: Assessment of Hepatocarcinoma Response to Radiofrequency

Aberrant Methylation of the Netrin-1 Receptor Genes UNC5C and DCC Detected in Advanced Colorectal Cancer

Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?

Characteristics of Esophagorespiratory Fistulas Resulting from Esophageal Cancers: A Single-Center Study on 243 Cases in a 20-Year Period